Since the COVID-19 Pandemic began, in early 2020, marginalized and vulnerable populations have been especially, adversely, impacted. NASW’s Connect to End COVID-19 initiative was launched to provide equitable training and outreach that promote informed vaccine decision-making on the part of social workers and their clients, particularly among those who are vulnerable, marginalized, and/or vaccine hesitant. NASW-KY recognizes our potential to promote vaccine confidence across the state, encourage reluctant communities to become vaccinated, and provide valuable resources for our Kentucky neighbors. We encourage you to explore our Connect to End COVID-19 resources and find ways to encourage positive community health through vaccine promotion in our communities.
Kentucky Coronavirus Monitoring
Since the beginning of the COVID-19 pandemic, the Kentucky Department for Public Health (KDPH) has coordinated state guidance with the recommendations from the U.S. Centers for Disease Control and Prevention (CDC). As CDC transitions to the new “COVID-19 Community Level” model that uses the number of new COVID-19 cases in each county, percent of hospital capacity devoted to COVID-19 patients and the number of new patients with COVID-19 admitted to the hospital in the past week, KDPH will be using this tool to help Kentuckians be informed of the COVID-19 impact in their communities. KDPH created the Community Level COVID-19 Guidance to align with the new community level model. This guidance provides Kentuckians with actions to take related to their local level of community burden. KDPH will continue to closely monitor COVID-19 data and provide weekly updates on the KDPH COVID-19 website. We appreciate the understanding and cooperation as we learn to live with COVID-19 and work to keep Kentuckians safe. For more information on the new tool provided by CDC, please visit the CDC website: COVID-19 by County.
Community Level COVID-19 Guidance
|
|
LOW
|
MEDIUM
|
HIGH
|
| Vaccination
|
Stay up to date with vaccinations
|
Stay up to date with vaccinations
|
Stay up to date with vaccinations
|
| Mask use
|
Mask based on individual preference, informed by individual risk
Targeted mask use in schools and other indoor settings following exposures
|
Consider universal mask use in indoor congregate settings
Targeted mask use in schools and other indoor settings following exposures
|
Wear well-fitting masks in all indoor public settings including K-12 schools
|
| Isolation & Quarantine
|
Stay home when sick
Follow isolation & quarantine guidance, including getting tested if exposed or have symptoms of COVID-19
|
Stay home when sick
Follow isolation & quarantine guidance, including getting tested if exposed or have symptoms of COVID-19
|
Stay home when sick
Follow isolation & quarantine guidance, including getting tested if exposed or have symptoms of COVID-19
|
| Physical distancing
|
|
|
Limit indoor in-person gatherings and reduce size of gatherings. Encourage physical distancing.
|
| High risk persons
|
Talk to healthcare provider about preventative treatments
|
Consider wearing well-fitted mask in all indoor public settings
Talk to healthcare provider about preventative treatments
|
Consider avoiding non-essential indoor public activities
Talk to healthcare provider about preventative treatments
|
COVID-19 VACCINE AND BOOSTERS
|
|
Pfizer
|
Moderna
|
Janssen/Johnson & Johnson
|
| Age
Recommended
|
5+ years old
|
18+ years old
|
18+ years old
|
| Primary
Series
|
2 doses
Given 3 weeks (21 days) apart.
|
2 doses
Given 4 weeks (28 days) apart.
|
1 dose
|
| Booster
Dose
|
You should get a booster dose at least 5 months after the last dose in their primary series.
|
You should get a booster dose at least 5 months after the last dose in their primary series.
|
You should get a booster dose of either Pfizer-BioNTech or Moderna (mRNA COVID-19 vaccines) at least 2 months after the first dose of J&J/Janssen COVID- 19 Vaccine.
|
| When am I
"up-to-date"?
|
2 dose primary series less than 5 months ago OR booster 5 months after completion of primary series.
|
2 dose primary series less than 5 months ago OR booster 5 months after completion of primary series.
|
1 dose primary series less than 2 months ago OR booster 2 months after completion of primary series.
|
| When am I "up-to-date" if I am moderately of severely immunocompromised?
|
2 dose series less than 28 days ago; or 1 additional dose (3rd dose to complete primary series) less than 3 months ago;
or
Booster (4th dose) 3 months after completion of primary 3 dose series.
|
2 dose series less than 28 days ago; or 1 additional dose (3rd dose to complete primary series) less than 3 months ago;
or
Booster (4th dose) 3 months after completion of primary 3 dose series.
|
1 dose primary series less than 28 days ago; 1 additional dose (2nd dose, Moderna or Pfizer) less than 2 months ago; Booster dose 2 months after second dose preferably with Moderna or Pfizer (3 total doses).
|
| 2nd Booster Dose
|
Ages 12+ immunocompromised or Ages 50+
|
Ages 12+ immunocompromised or Ages 50+
|
50+ or those that are immunocompromised SHOULD receive a second booster with a mRNA;
18-49 who received JJ for primary and booster MAY receive 2nd booster with mRNA
|